A recent paper investigated lncRNAs as biomarkers for predicting survival in MM patients [20]; in addition, MALAT1 (metastasis-associated lung adenocarcinoma transcript 1), a putative oncogenic lncRNA overexpressed in several solid tumors [21, 22], has been found overexpressed in MM and may represent a marker to predict MM progression [23]. Here, MALAT1 is linked to Miyoshi myopathy.